Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Alligator Bioscience contracts Theradex Oncology as clinical CRO for the upcoming ATOR-1015 phase I study

Lund, Sweden, 25 January – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that it has appointed Theradex Oncology, a global contract research organization ("CRO") with extensive expertise in oncology clinical development, as CRO for the planned phase I study of ATOR-1015 for the treatment of metastatic cancer. The study is expected to commence in the second half of 2018. The upcoming clinical phase I study with ATOR-1015 is a first-in-human dose escalation study in

BAKKAFROST: REFINANCING

Bakkafrost is pleased to announce an agreement to refinance its existing bank facilities and its outstanding NOK 500m bond, which has a maturity during Q1 2018, with a senior secured five year EUR 200m credit facility ("Facility"), with its existing lender Nordea. The Facility includes an accordion increase option, which provides flexibility for the parties to agree an increased size of the facility by further up to EUR 200 million during the term of Facility. The principal financial covenants of the Facility are; (1) an equity ratio of no less than 35% and (2) an interest coverage

Castellum’s Year-end Report 2017: 5% growth in income from property management and a proposed dividend of SEK 5.30 per share

· Rental income for 2017 amounted to SEKm 5,182 (SEKm 4,533 previous year). · Income from property management amounted to SEKm 2,530 (2,065), corresponding to SEK 9.26 (8.80) per share. An increase in absolute terms of 23% and in SEK/share of 5%. · Changes in value on properties amounted to SEKm 4,540 (4,085) and on derivatives to SEKm 247 (82). · Net income after tax for the year amounted to SEKm 5,876 (4,972), corresponding to SEK 21.51 (21.20) per share. · Long term net asset value amounted to SEK 153 (133) per share. An increase of 15%.   · Net investments amounted to

Year- end report January - December 2017

Execution of the new strategy continues according to plan. The Byggmax segment has come furthest, and execution of the strategicinitiatives has positively contributed to the Byggmax segment’s strong profitability improvement in 2017 (adjusted EBITDA margin+0.7%-points. Skånska Byggvaror is in the middle of a transformation, and in the fourth quarter, the cost base is restructured. Financial results for the fourth quarter are impacted by the execution of our strategic plan, a soft Nordic consumer market for buildingmaterials affected by early autumn weather, and the weaker NOK. In the

Trading and operations update

25 January 2018 Genel Energy plc Trading and operations update Genel Energy plc (‘Genel’ or ‘the Company’) issues the following trading and operations update in advance of the Company's full-year 2017 results, which are scheduled for release on 22 March 2018. The information contained herein has not been audited and may be subject to further review. Murat Özgül, Chief Executive of Genel, said: "A strong final quarter of 2017 completed a very positive year for Genel. During the quarter, the successful Peshkabir-3 well result tripled production at the field to c.15,000 bopd, a

Lagercrantz Interim Report 2017/18 Q3

Third quarter 1 October – 31 December 2017 · Net revenue increased by 11 percent to MSEK 888 (798). · Operating profit (EBITA) increased by 7 percent to MSEK 111 (104), equivalent to an operating margin of 12.5 percent (13.0). · Profit before financial items amounted to MSEK 96 (92), equivalent to an EBIT margin of 10.8 percent (11.5). · Profit after financial items amounted to MSEK 91 (89) and profit after taxes amounted to MSEK 70 (68). · Earnings per share after dilution for the latest 12-month period amounted to SEK 4.07 (3.82). · Return on equity was 23 percent (25).

Year-end report January 1 - December 31, 2017

Focus on enhancing profitability and reducing overheads· Orders received amounted to SEK 16,295 M (16,267) in the fourth quarter and to SEK 56,990 M (56,506) for the January-December period · Net sales totaled SEK 16,318 M (16,519) in the fourth quarter and SEK 54,608 M (52,934) for the January-December period · The Group reported a loss after financial items of SEK 19 M (profit: 630) in the fourth quarter and a profit of SEK 1,150 M (profit: 1,341) for the January-December period · Profit after tax was SEK 34 M (501) in the fourth quarter and SEK 1,009 M (1,116) for the January-

Read original

Full Year Report incl. Q4 2017

Strengthened financial position and continued profitability  Financial overview Q4 2017 · Total net revenues SEK 191.0 million (184.7) · Zubsolv® US net revenue SEK 126.5 million (128.2). In local currency a growth of 7.2 percent.  · EBIT SEK 30.1 million (33.2) · EBITDA SEK 35.3 million (44.1) · Earnings per share, before and after dilution, SEK 0.77/0.77 (0.97/0.96) · Cash flow from operating activities SEK -23.0 million (71.4) · Cash and cash equivalents SEK 327.9 million (282.4) Financial overview Full Year 2017 · Total net revenues SEK 643.7 million (

Stora Enso’s items affecting comparability in Q4 2017

STORA ENSO OYJ INVESTOR NEWS 25 January 2018 at 9.00 EETStora Enso will record items affecting comparability (IAC) with a negative total impact of approximately EUR 29 million on its operating profit and a positive impact of approximately EUR 4 million on income tax in the fourth quarter of 2017. The IAC relate mainly to the disposal of Puumerkki, a specialised wholesaler of wooden building materials, and environmental provisions in various locations. Allocation of the IAC between segments  EUR million Consumer Board 1Packaging Solutions 0

Q4 2017: Probi achieves major milestone in expansion of Functional Food business area

Highlights and significant events in the fourth quarter · Major agreement signed with global FMCG leader to launch Functional Food product in North America in 2019 · Important product launches of FerroSorb® and Probi Select™ in North America start to deliver cross-selling synergies in Consumer Healthcare · Submission of new health claim application to EFSA for iron uptake product FerroSorb® following positive results in supplementary study · Board of Directors and CEO propose that the 2018 Annual General Meeting resolves that no dividends will be paid for the 2017 financial

Orkla ASA: Invitation to presentation of Orkla's fourth quarter 2017 results, Thursday 8 February

Orkla will report its fourth quarter 2017 results on Thursday, 8 February 2018 at 7.00 a.m. CET. The quarterly report and the presentation material will be available at this time at www.orkla.com.The quarterly results will be presented at 8.00 a.m. in Oslo Concert Hall, Munkedamsveien 14, Oslo. The presentation and subsequent Q&A session will be held in English and may be viewed in a live webcast at www.orkla.com or followed by telephone. Dial-in details: +47 21 03 33 94. Pincode: 6491460.Orkla ASAOslo, 25 January 2018Ref.:IR & Communications ManagerElise HeidenreichTel.: +47

ERAS® – VALUE BASED SURGERY – FINANCIAL IMPLICATIONS

A recently published article by professors Ljungqvist, Thanh and Nelson in the Journal of Surgical Oncology reviews the implementation of ERAS and its financial implication. Reports from many different surgery types show that implementation of ERAS reduces complications and shortens hospital stay. These improvements have major impacts on reducing the cost of care even when costs for implementation and investment in time for personnel and training are accounted for. The conclusion is that ERAS is an excellent example of value-based surgery. Read more 

SSM’s sales of number of cooperative apartments up 10.3 percent in 2017

SSM Holding AB (publ), the leading property developer in the Stockholm region within affordable and space-efficient homes, increased the number of cooperative apartments sold in 2017 by 10.3 percent compared with 2016. The sales rate for cooperative apartments in production remains at a market-leading level and at year-end 2017, it was 97.0 percent. During the year, production of 204 cooperative apartments began and by the end of the year, there were 1,414 homes in productionThe demand for smaller apartments continues to be strong in the Greater Stockholm area despite turbulence in the

Lifestyle changes prevent cognitive decline even in genetically susceptible individuals

Enhanced lifestyle counselling prevents cognitive decline even in people who are carriers of the APOE4 gene, a common risk factor of Alzheimer’s disease, according to a new study published in JAMA Neurology. The two-year FINGER trial involved 60–77 year-old people living in Finland and with risk factors for memory disorders. The study participants were divided into two groups: one of the groups was given regular lifestyle counselling and the other enhanced lifestyle counselling. Enhanced counselling involved nutrition counselling, physical and cognitive exercises, and support in managing

Invitation to Kungsleden’s Year-End Report Presentation on February 15 at 8.45 and 10.15 am (CET)

On February 15, 2018 at 7.00 am (CET) Kungsleden AB (publ) will publish its Year-End Report for 2017.Accordingly, Kungsleden invites investors, asset managers, financial analysts and the press to presentations where CEO Biljana Pehrsson and Deputy CEO and CFO Anders Kvist will present and comment on the Year-End Report. At 8.45 am (CET) a live presentation in Swedish will be held and at 10.15 am (CET) a presentation in English will be held via telephone conference. Both sessions will include a Q&A section. The report will be published at 7.00 am and available for download at www.

Nomination Committee’s proposals to Nordea’s Annual General Meeting 2018

The Nomination Committee of Nordea Bank AB (publ) was established by decision of the annual general meeting 2017 and comprises Torbjörn Magnusson, chairman of the Nomination Committee, appointed by Sampo plc, Mogens Hugo, appointed by Nordea-fonden, Katarina Thorslund, appointed by Alecta, Anders Oscarsson, appointed by AMF and AMF Funds, and Björn Wahlroos, chairman of the board of directors. Today the Nomination Committee announces its proposals to Nordea’s annual general meeting on 15 March 2018. The proposals will also be presented in the notice to attend the meeting. Election of

Leading Humanitarian Organisations Object to Trump Administration’s Decision to Cut U.S. Contributions to the UN Relief Agency for Palestinians

Washington, D.C. – Today, the leaders of 21 leading organisations involved in international humanitarian response sent a letter to the Trump Administration objecting “in the strongest terms” to the U.S. decision to withhold US$65 million of the planned contributions to the United Nations Relief and Works Agency (UNRWA) for Palestinian refugees in the Middle East. In the letter (reproduced further down), the humanitarian leaders write: “We are deeply concerned by the humanitarian consequences of this decision on life-sustaining assistance to children, women and men in Jordan, Lebanon,

Fourth Quarter and Full Year Results 2017

CEO Casper von Koskull’s comments on the results: “In 2017, volumes and margins were relatively stable, and business momentum was solid overall. At the end of 2017, we were negatively impacted by a very low activity level on capital markets. The planned de-risking of the bank, with reduced exposure to Russia, Shipping, Offshore & Oil Services, also reduced income levels.   After years of intense investments, things are happening now and we are entering the next stage on our transformation journey. We have built up our capabilities within compliance and risk management functions. Our

Arbitral award rendered in Enea’s dispute with a large customer

Enea has previously communicated the initiation and progress of the arbitration proceedings between Enea and one of the company’s largest customers, see press releases of November 3, 2016 and November 16, 2017. Enea has now received the arbitral award. The arbitral tribunal denied one part of Enea’s case, where Enea had indicated preliminary claims for additional royalties of as much as SEK 900 million, but accepted another, smaller, part of Enea’s case. Both parts of Enea’s case concerned how the royalty provisions in the contract with the customer should be interpreted. The arbitral

Meyer Optik Announces Exclusive Club for Trioplan Trilogy Photographers

Backers of New Indiegogo Campaign Get Members-Only Perks, Including International Photo Exhibits(Goerlitz, Germany) Meyer Optik announced its Trioplan Gold Art Club today, an exclusive and limited program that provides members exclusive perks, including having their work exhibited internationally, getting insiders-only information on upcoming projects and receiving discounts on lens purchases. Membership in the Gold Art Club is exclusive to photographers who purchase the Trioplan Trilogy of lenses (the 100, 50 and 35mm lenses) through a crowd-funding campaign that launched today on

Starbreeze intends to carry out a directed share issue for continued expansion and high-power release of OVERKILL’s The Walking Dead

THE INFORMATION IN THIS PRESS RELEASE MAY NOT BE ANNOUNCED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, UNITED STATES, OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, PUBLICATION OR DISTRIBUTION OF THE INFORMATION WOULD NOT COMPLY WITH OR REQUIRE REGISTRATION UNDER APPLICABLE LAWS AND REGULATIONS. STOCKHOLM (24 January 2018) Starbreeze AB (publ) (”Starbreeze” or the ”Company”) has mandated Carnegie Investment Bank to evaluate the conditions for a directed share issue of

Reminder: Invitation – DNB’s fourth quarter results for 2017 will be presented on Thursday 1 February

DNB will publish its results for the fourth quarter of 2017 on Thursday, 1 February 2018 at 7.30 am CET. 1 February at 9.30 am CET: press conference in English accessible via live web TVPlace: DNB’s head office in Bjørvika, Dronning Eufemias gate 30, Oslo. A live broadcast will be available on the Investor Relations pages at ir.dnb.no.Please register your attendance in Oslo at ca@dnb.no (ca@dnb.no?Subject=Registration%20DNB%20Quarterly%20Presentation%20Oslo). The press conference will be held in English. 1 February at 1.30 pm CET: conference call for analysts and investorsTo

Valutec supplies local Swedish sawmills with their first TC continuous kilns – investments from Martinsons and Norra Skogsägarna (Norra Group)

Following a year where Valutec grew on several international markets, 2018 is off to a flying start with three major deliveries to Västerbotten county in the norhern parts of Sweden. These were Martinsons, who invested in one TC continuous kiln and five batch kilns in Bygdsiljum, and Norra Skogsägarna who invested in TC continuous kilns for their sawmills in Kåge and Sävar. Both companies made investments as a key part of comprehensive increases in production.“It's fantastic to see our regional sawmills developed, and also an honor that they chose us as their partner in major future

There are no items matching the current filter
There are no more items matching the current filter
Back to top